[Mechanisms of myocardial ischemia and circadian fluctuations of ischemic episodes]
- PMID: 1535951
[Mechanisms of myocardial ischemia and circadian fluctuations of ischemic episodes]
Abstract
The circadian variation of angina pectoris, myocardial infarction and sudden death, with a first peak in the early morning and a second one in the late afternoon, suggests that physical activity plays an important role in triggering ischemic events by an increase of cardiac oxygen demand. But there is also evidence of decreased oxygen supply related to a paradoxical catecholamine-induced vasoconstriction which reflects the endothelial dysfunction of atherosclerotic coronary arteries. Elevated blood pressure during daytime and other mechanical factors can facilitate a plaque-rupture which triggers formation of coronary thrombosis. Hypercoagulability in the early morning hours by increased platelet aggregability and by elevated levels of plasminogen-activator inhibitors may contribute to this fatal mechanism.
Similar articles
-
Circadian variation and triggers of acute coronary syndromes.Eur Heart J. 1998 Apr;19 Suppl C:C12-23. Eur Heart J. 1998. PMID: 9597421 Review.
-
Diurnal rhythms and clinical events in coronary artery disease.Postgrad Med J. 1991;67 Suppl 5:S44-7. Postgrad Med J. 1991. PMID: 1803340 Review.
-
[Genesis of myocardial infarction].Arch Mal Coeur Vaiss. 1984 Oct;77(10):1114-9. Arch Mal Coeur Vaiss. 1984. PMID: 6439147 French.
-
[Wake up time, thrombocyte aggregation and the risk of acute coronary heart disease. The TRIMM (Trigger and Mechanisms of Myocardial Infarct) Study Group].Z Kardiol. 1992;81 Suppl 2:95-9. Z Kardiol. 1992. PMID: 1514322 Clinical Trial. German.
-
The role of coronary arterial spasm in ischemic heart disease.Arch Pathol Lab Med. 1981 May;105(5):221-6. Arch Pathol Lab Med. 1981. PMID: 6894363
Cited by
-
The effect of time of day and exercise on platelet functions and platelet-neutrophil aggregates in healthy male subjects.Mol Cell Biochem. 2005 Dec;280(1-2):119-24. doi: 10.1007/s11010-005-8238-8. Mol Cell Biochem. 2005. PMID: 16311912 Clinical Trial.